CALT

Calliditas Therapeutics AB

Price

return (12m)

p/e

-23.92

p/bv

106.09

DIVIDEND YIELD

0.00%

CALT price

Calliditas Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment CALT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CALT

Valuation

P/E

-23.92

Sector 0.84

Industry -1.42

P/BV

106.09

Sector 1.82

Industry 1.25

P/Revenue (PSR)

7.09

Sector 1.48

Industry 2.13

EV/EBITDA

-391.23

Sector -43.66

Industry -35.45

EV/EBIT

-391.23

Sector -47.57

Industry -38.86

P/EBITDA

-32.82

Sector -31.25

Industry -21.12

P/EBIT

-32.82

Sector -42.58

Industry -25.59

P/Total Assets

6.48

Sector 0.82

Industry 0.70

P/Net Current Assets

-23.31

Sector -23.77

Industry -59.56

P/Working Capital

15.63

Sector -3.73

Industry -1.93

EPS

-1.67

Sector -0.70

Industry -1.22

BVPS

0.38

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

93.46%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-5.62%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-21.60%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-29.63%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.32

Sector 0.13

Industry 0.06

Profitability

ROE

-443.52%

Sector -24.30%

Industry -38.97%

ROA

-27.10%

Sector -24.50%

Industry -49.14%

ROIC

-22.50%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.69

Sector 1.92

Industry 2.55

Net Debt / EBITDA

-31.23

Sector -23.10

Industry -8.80

Net Debt / EBIT

-31.23

Sector -17.84

Industry -36.75

Net Debt / Equity

9.20

Sector -0.68

Industry -1.16

Gross Debt / Equity

9.20

Sector -0.72

Industry -0.54

Equity/Assets

0.06

Sector 0.46

Industry 0.52

Liabilities/Assets

0.06

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

46.05%

Sector -

Industry -

5Y Earnings CAGR

20.29%

Sector -

Industry -

Fundamentals CALT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CALT Calliditas Therapeutics AB	$0.00	-	0.00%	-23.92	106.09	-443.52%	-29.63%
LLY Eli Lilly and Compay	$1,249.76	56.65%	0.53%	42.13	33.21	78.84%	33.53%
SNY Sanofi	$39.81	-18.25%	4.38%	3.78	0.70	18.43%	14.25%
GSK GlaxoSmithKline PLC	$49.36	16.30%	3.58%	15.38	4.34	28.24%	14.54%
CRMD CorMedix Inc.	$7.48	-26.52%	0.00%	3.04	1.23	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$25.97	9.21%	0.00%	14.41	1.47	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$13.05	-9.04%	0.64%	29.37	2.65	9.03%	10.14%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
NVS Novartis AG	$150.19	16.49%	2.05%	22.56	6.86	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$673.79	25.46%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
DHR Danaher Corporation	$224.14	8.20%	0.63%	40.42	3.08	7.61%	15.95%
HCA HCA Healthcare Inc.	$454.64	7.19%	0.66%	14.90	-31.76	-213.15%	8.77%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CALT - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Calliditas Therapeutics

Calliditas Therapeutics AB

Average Investor10 user rating

4.0 (0 people)

United States

22 years

Founded: 2004

2020

Time since IPO - 6 years

23

Employees

Calliditas Therapeutics AB (United States) is listed on the Nasdaq and has a market capitalization of $1.08 billion, with shareholders equity totaling $10.18 million.

The company employs approximately 23 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Calliditas Therapeutics AB reported $152.36 million in revenue, generating net income of $-45.15 million.

Key financial metrics include a P/E ratio of -23.92, a price-to-book (P/B) ratio of 106.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CALT.

Market cap

$1.08 billion

Net worth

$10.18 million

$10,180,000.00

Assets

$166.61 million

$166,610,000.00

Total Shares Outstanding

27.00 million

27,000,000

Average Daily Trading Volume

$8.08 Thousand

$8,079.12

Sector

Health

Industry

Pharmaceutical Products

CALT

CALT revenue and profits

Financial Results CALT

DRAG THE FRAME TO SEE MORE DATA

CALT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76